Oncology Research2026，Vol.34Issue(1)：P.297-324,28.DOI:10.32604/or.2025.066662
ZMIZ2/MCM3 Axis Participates in Triple-Negative Breast Cancer Progression
Xiaopan Zou 1Meiyang Sun 2Xin Jiang 3Jingze Yu 4Xiaomeng Li 5Bingyu Nie3
作者信息
- 1. Breast and Thyroid Surgery,Jilin Province People’s Hospital,Changchun,130021,China The Key Laboratory of Molecular Epigenetic,Institute of Genetics and Cytology,Northeast Normal University,Changchun,130024,China
- 2. Plastic Surgery Department,Shenzhen Art Star Medical Cosmetology Hospital,Shenzhen,518000,China
- 3. Breast and Thyroid Surgery,Jilin Province People’s Hospital,Changchun,130021,China
- 4. The Key Laboratory of Molecular Epigenetic,Institute of Genetics and Cytology,Northeast Normal University,Changchun,130024,China
- 5. King Med School of Laboratory Medicine,Guangzhou Medical University,Guangzhou,510182,China
- 折叠
摘要
关键词
Triple-negative breast cancer/zinc finger miz-type containing 2/minichromosome maintenance complex component 3/pathway enrichment analysis分类
医药卫生引用本文复制引用
Xiaopan Zou,Meiyang Sun,Xin Jiang,Jingze Yu,Xiaomeng Li,Bingyu Nie..ZMIZ2/MCM3 Axis Participates in Triple-Negative Breast Cancer Progression[J].Oncology Research,2026,34(1):P.297-324,28.基金项目
supported by the Jilin Province Health Science and Technology Ability Improvement Project(2023JL057). （2023JL057）
